CDER Risk Assessment Exercise to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products

被引：12

作者：

Cruz, Celia N. ^{[1
]}

Tyner, Katherine M. ^{[1
]}

Velazquez, Lydia ^{[1
]}

Hyams, Kenneth C. ^{[1
]}

Jacobs, Abigail ^{[1
]}

Shaw, Arthur B. ^{[1
]}

Jiang, Wenlei ^{[1
]}

Lionberger, Robert ^{[1
]}

Hinderling, Peter ^{[1
]}

Kong, Yoon ^{[1
]}

Brown, Paul C. ^{[1
]}

Ghosh, Tapash ^{[1
]}

Strasinger, Caroline ^{[1
]}

Suarez-Sharp, Sandra ^{[1
]}

Henry, Don ^{[1
]}

Van Uitert, Maat ^{[1
]}

Sadrieh, Nakissa ^{[1
]}

Morefield, Elaine ^{[1
]}

机构：

[1] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA

来源：

AAPS JOURNAL | 2013年 / 15卷 / 03期

关键词：

CDER; nanomaterial; nanotechnology; risk assessment; risk management;

D O I：

10.1208/s12248-013-9466-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The Nanotechnology Risk Assessment Working Group in the Center for Drug Evaluation and Research (CDER) within the United States Food and Drug Administration was established to assess the possible impact of nanotechnology on drug products. The group is in the process of performing risk assessment and management exercises. The task of the working group is to identify areas where CDER may need to optimize its review practices and to develop standards to ensure review consistency for drug applications that may involve the application of nanotechnology. The working group already performed risk management exercises evaluating the potential risks from administering nanomaterial active pharmaceutical ingredients (API) or nanomaterial excipients by various routes of administration. This publication outlines the risk assessment and management process used by the working group, using nanomaterial API by the oral route of administration as an example.

引用

页码：623 / 628

页数：6

共 50 条

[1] CDER Risk Assessment Exercise to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products
Celia N. Cruz
Katherine M. Tyner
Lydia Velazquez
Kenneth C. Hyams
Abigail Jacobs
Arthur B. Shaw
Wenlei Jiang
Robert Lionberger
Peter Hinderling
Yoon Kong
Paul C. Brown
Tapash Ghosh
Caroline Strasinger
Sandra Suarez-Sharp
Don Henry
Maat Van Uitert
Nakissa Sadrieh
Elaine Morefield
The AAPS Journal, 2013, 15 : 623 - 628
[2] Assessment Tool to Measure and Evaluate the Risk Potential of Gambling Products: AsTERiG
Peren, Franz W.
GAMING LAW REVIEW-ECONOMICS REGULATION COMPLIANCE AND POLICY, 2011, 15 (11): : 671 - 679
[3] Assessment Tool to Measure and Evaluate the Risk Potential of Gambling Products, ASTERIG: A Global Validation
Blanco, Carlos
Blaszczynski, Alex
Clement, Reiner
Derevensky, Jeffrey
Goudriaan, Anna E.
Hodgins, David C.
van Holst, Ruth J.
Ibanez, Angela
Martins, Silvia S.
Moersen, Chantal
Molinaro, Sabrina
Parke, Adrian
Peren, Franz W.
Petry, Nancy M.
Wardle, Heather
GAMING LAW REVIEW-ECONOMICS REGULATION COMPLIANCE AND POLICY, 2013, 17 (09): : 635 - 642
[4] HUMAN HEALTH RISKS OF ENGINEERED NANOMATERIALS Critical Knowledge Gaps in Nanomaterials Risk Assessment
Elder, A.
Lynch, I.
Grieger, K.
Chan-Remillard, S.
Gatti, A.
Gnewuch, H.
Kenawy, E.
Korenstein, R.
Kuhlbusch, T.
Linker, F.
Matias, S.
Monteiro-Riviere, N.
Pinto, V. R. S.
Rudnitsky, R.
Savolainen, K.
Shvedova, A.
NANOMATERIALS: RISKS AND BENEFITS, 2009, : 3 - +
[5] Generic assessment of novel risks related to the use of engineered nanomaterials
Prodanov, D.
2018 IEEE 18TH INTERNATIONAL CONFERENCE ON NANOTECHNOLOGY (IEEE-NANO), 2018,
[6] Problems with the use of risk-assessment approaches to estimate differences in health risks from various smoking products
Lauterbach, John H.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[7] Problems with the use of risk-assessment approaches to estimate differences in health risks from various smoking products
Lauterbach, John H.
CHEMICAL RESEARCH IN TOXICOLOGY, 2007, 20 (12) : 2015 - 2015
[8] ASSESSMENT OF POTENTIAL HEALTH RISKS FROM DERMAL EXPOSURE TO DIOXIN IN PAPER PRODUCTS
KEENAN, RE
SAUER, MM
LAWRENCE, FH
CHEMOSPHERE, 1989, 19 (1-6) : 877 - 882
[9] Genetic risk assessment: Current strategies to evaluate transgenic risks
Good, Allen
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238 : 578 - 578
[10] Enterococci isolated from dairy products: A review of risks and potential technological use
Giraffa, G
Carminati, D
Neviani, E
JOURNAL OF FOOD PROTECTION, 1997, 60 (06) : 732 - 737

← 1 2 3 4 5 →